Peter Svennilson, Director at Revolution Medicines, Inc. (RVMD), sold 152,720 shares at $42.85 ($6.5M) on 2021-04-26, disclosed to the SEC on 2021-04-28.
Open-market sale of $6.5M RVMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.85 | 24,883 | $1.1M | 16.3% |
| 2 | $42.85 | 24,883 | $1.1M | 16.3% |
| 3 | $42.85 | 28,101 | $1.2M | 18.4% |
| 4 | $42.85 | 28,101 | $1.2M | 18.4% |
| 5 | $42.65 | 10,955 | $467K | 7.2% |
| 6 | $42.65 | 10,955 |
| $467K |
| 7.2% |
| 7 | $42.65 | 12,371 | $528K | 8.1% |
| 8 | $42.65 | 12,371 | $528K | 8.1% |
| 9 | $42.50 | 47 | $2K | 0.0% |
| 10 | $42.50 | 53 | $2K | 0.0% |
| Total | $42.79 avg | 152,720 | $6.5M | 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |